Fund
Perceptive Advisors
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 0
- New entries
- 2
- Follow ons
- 0
- Latest operation
- 3 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 03 Sept | United States, Biotech | Series B | 60 M$ | Participant |
| 11 Aug | Switzerland, Biotech | Series B | 152 M$ | Participant |
Co investors 16 funds crossed
- BVF Partners 1 operation
- Catalio Capital Management 1 operation
- Cooley 1 operation
- Deep Track Capital 1 operation
- Droia Ventures 1 operation
- Eli Lilly and Company 1 operation
- EQT Life Sciences 1 operation
- Gaingels 1 operation
- Insight Partners 1 operation
- Kalehua Capital 1 operation
- Life Sciences at Goldman Sachs Alternatives 1 operation
- Medicxi 1 operation
- NVIDIA 1 operation
- Omega Funds 1 operation
- RA Capital Management 1 operation
- TCGX 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, Switzerland.